Insulin replacement corrects insulin deficiency and hyperglycaemia but does not treat the underlying autoimmune T lymphocyte–mediated destruction of the insulin-producing β cells of the pancreatic islets [1]. The gene discussed is INS; the disease is Hyperglycemia.